- Home
- VREX vs ALMS Comparison
VREX vs ALMS Comparison
Compare VREX & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VREX
- ALMS
- Stock Information
- Founded
- VREX 2016
- ALMS 2021
- Country
- VREX United States
- ALMS United States
- Employees
- VREX N/A
- ALMS N/A
- Industry
- VREX Industrial Machinery/Components
- ALMS
- Sector
- VREX Technology
- ALMS
- Exchange
- VREX Nasdaq
- ALMS NYSE
- Market Cap
- VREX 343.3M
- ALMS 402.6M
- IPO Year
- VREX N/A
- ALMS 2024
- Fundamental
- Price
- VREX $8.19
- ALMS $3.52
- Analyst Decision
- VREX Strong Buy
- ALMS Strong Buy
- Analyst Count
- VREX 2
- ALMS 7
- Target Price
- VREX $22.50
- ALMS $24.50
- AVG Volume (30 Days)
- VREX 389.9K
- ALMS 841.5K
- Earning Date
- VREX 07-31-2025
- ALMS 08-12-2025
- Dividend Yield
- VREX N/A
- ALMS N/A
- EPS Growth
- VREX N/A
- ALMS N/A
- EPS
- VREX N/A
- ALMS N/A
- Revenue
- VREX $827,500,000.00
- ALMS $17,389,000.00
- Revenue This Year
- VREX $0.73
- ALMS N/A
- Revenue Next Year
- VREX $4.40
- ALMS N/A
- P/E Ratio
- VREX N/A
- ALMS N/A
- Revenue Growth
- VREX N/A
- ALMS N/A
- 52 Week Low
- VREX $6.76
- ALMS $2.76
- 52 Week High
- VREX $16.93
- ALMS $13.50
- Technical
- Relative Strength Index (RSI)
- VREX 52.63
- ALMS N/A
- Support Level
- VREX $8.28
- ALMS N/A
- Resistance Level
- VREX $8.83
- ALMS N/A
- Average True Range (ATR)
- VREX 0.36
- ALMS 0.00
- MACD
- VREX 0.01
- ALMS 0.00
- Stochastic Oscillator
- VREX 66.19
- ALMS 0.00
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.